Alessandra Ferri

Alessandra Ferri

Auto-generated profile, based on publicly available information

Alessandra Ferri

Department of Biology, University of Rome "Tor Vergata", 00133, Rome, Italy; Laboratory of Cell Signaling, IRCCS-Fondazione Santa Lucia, 00179, Rome, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2025 in Cancer Letters
Verified
Journal Article
Open access
AFAlessandra Ferri
Alessandra Ferri
CCClaudia Contadini
Claudia Contadini
CGClaudia Di Girolamo
Claudia Di Girolamo
CCClaudia Cirotti
Claudia Cirotti
Giulia FisconGiulia Fiscon
Giulia Fiscon
DBDaniela Barilà
Daniela Barilà
Caspase-8 is a cysteine protease historically regarded as anti-neoplastic protein, thanks to its role in apoptosis. However, Caspase-8 expression is retained or even enhanced in several tumors, including glioblastoma (GBM), where it plays pro-tumor functions. We previously reported that it is a negative prognostic factor and contributes to resistance against DNA damaging agents, such as ionizing radiations (IR) and Temozolomide, commonly used in standard GBM treatment. We therefore investigated whether Caspase-8 may sustain DNA repair pathways proficiency in GBM. Here we uncover a novel role of Caspase-8 as promoter of the Homologous Recombination Repair (HRR). Importantly, IR promote Caspase-8 transient nuclear translocation and its recruitment to the chromatin. Moreover, Caspase-8 sustains the expression and the recruitment to the chromatin upon IR of RAD51 and CtIP, two key players of the HRR. Consistently, we identify a synthetically lethal interaction between Caspase-8 and PARP inhibition, that may enhance GBM sensitivity to IR. Remarkably, by using Caspase-8-/- murine embryo fibroblasts and a Drosophila melanogaster Caspase-8 mutant, we demonstrate that Caspase-8 plays an evolutionary conserved role in DNA repair.